Hims & Hers Health (HIMS)

NYSE Health Care Health Care Services S&P MidCap 400

$26.00

+1.94 (+8.06%)

Close of Nov 06, 2026 · end-of-day data

Source: Hims & Hers Health's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$82.56M	$148.76M	$271.88M	$526.92M	$872.00M	$1.48B	$2.35B
Cost of revenue	$37.95M	$39.31M	$67.38M	$118.19M	$157.05M	$303.38M	$614.26M
Gross profit	$44.60M	$109.45M	$204.49M	$408.72M	$714.95M	$1.17B	$1.73B
Selling, general & admin	$55.86M	$65.61M	$183.63M	—	—	—	—
Operating income	-$74.41M	-$15.14M	-$115.04M	-$68.70M	-$29.45M	$61.90M	$105.61M
Interest expense	$369.00K	$10.00K	$0	—	—	—	—
Pre-tax income	-$71.97M	-$17.99M	-$110.80M	-$65.71M	-$21.57M	$71.71M	$123.92M
Income tax	$90.00K	$127.00K	-$3.14M	-$31.00K	$1.98M	-$54.33M	-$4.44M
Net income	-$72.06M	-$18.11M	-$107.66M	-$65.68M	-$23.55M	$126.04M	$128.37M
EBITDA	-$74.15M	-$14.09M	-$110.97M	-$61.22M	-$19.94M	$78.99M	$160.12M
EPS (basic)	$-2.07	$-0.51	$-0.58	$-0.32	$-0.11	$0.58	$0.57
EPS (diluted)	$-2.07	$-0.51	$-0.58	$-0.32	$-0.11	$0.53	$0.51
Diluted shares	34.76M	35.35M	186.78M	204.52M	209.34M	236.81M	258.23M
Gross margin	54.0%	73.6%	75.2%	77.6%	82.0%	79.5%	73.8%
Operating margin	-90.1%	-10.2%	-42.3%	-13.0%	-3.4%	4.2%	4.5%
Net margin	-87.3%	-12.2%	-39.6%	-12.5%	-2.7%	8.5%	5.5%

Balance sheet

fiscal years · USD

Fiscal year	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$22.65M	$27.34M	$71.78M	$46.77M	$96.66M	$220.58M	$228.62M
Short-term investments	$37.72M	$72.86M	$175.49M	$132.85M	$124.32M	$79.67M	$348.88M
Receivables	—	$1.10M	$4.10M	$3.90M	$6.70M	$6.10M	$32.10M
Inventory	$4.22M	$3.54M	$13.56M	$21.56M	$22.46M	$64.43M	$80.13M
Total current assets	$69.61M	$113.08M	$269.90M	$216.59M	$265.05M	$395.83M	$767.64M
Goodwill	—	$0	$110.88M	$110.88M	$110.88M	$112.73M	$278.32M
Total assets	$72.07M	$118.70M	$420.58M	$366.34M	$441.19M	$707.54M	$2.15B
Total current liabilities	$20.62M	$15.23M	$79.22M	$47.94M	$88.47M	$221.37M	$404.43M
Short-term debt	$1.51M	$0	—	—	—	—	—
Total debt	$1.51M	$0	—	—	—	—	—
Total liabilities	$20.62M	$15.61M	$85.97M	$54.60M	$97.16M	$230.82M	$1.61B
Shareholders' equity	-$139.79M	-$146.87M	$334.62M	$311.74M	$344.03M	$476.72M	$540.93M

Cash flow

fiscal years · USD

Fiscal year	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$74.87M	-$2.48M	-$34.41M	-$26.53M	$73.48M	$251.08M	$300.01M
Capital expenditures	—	—	—	$7.20M	$26.50M	$52.80M	$242.60M
Free cash flow	-$74.87M	-$2.48M	-$34.41M	-$33.73M	$46.98M	$198.28M	$57.41M
Investing cash flow	-$39.30M	-$39.70M	-$156.27M	$34.70M	-$12.11M	-$19.05M	-$1.02B
Financing cash flow	$95.32M	$47.74M	$235.04M	-$33.13M	-$11.47M	-$107.84M	$729.62M
Share buybacks	$0	$0	$0	$0	$2.00M	$83.04M	$89.96M
Stock-based compensation	$8.03M	$5.83M	$67.21M	$42.82M	$66.08M	$92.32M	$135.24M
Depreciation & amortization	$260.00K	$1.06M	$4.08M	$7.47M	$9.52M	$17.09M	$54.50M

Income statement

quarters · USD

Quarter ended	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$226.70M	$246.62M	$278.17M	$315.65M	$401.56M	$481.14M	$586.01M	$544.83M	$598.98M	$617.82M	$608.10M	$753.21M
Cost of revenue	$39.39M	$42.56M	$49.08M	$59.03M	$83.67M	$111.60M	$155.32M	$128.64M	$156.92M	$173.38M	$211.32M	$272.41M
Gross profit	$187.31M	$204.06M	$229.09M	$256.61M	$317.89M	$369.54M	$430.69M	$416.20M	$442.06M	$444.44M	$396.79M	$480.80M
Operating income	-$8.55M	-$400.00K	$9.90M	$11.03M	$22.37M	$18.60M	$57.90M	$26.72M	$11.81M	$9.19M	-$78.32M	-$97.19M
Pre-tax income	-$6.92M	$2.20M	$12.40M	$13.42M	$23.59M	$22.29M	$60.49M	$32.85M	$12.22M	$18.35M	-$101.55M	-$92.63M
Income tax	$651.00K	$951.00K	$1.27M	$127.00K	-$51.99M	-$3.73M	$11.01M	-$9.65M	-$3.55M	-$2.25M	-$9.44M	-$6.34M
Net income	-$7.57M	$1.25M	$11.13M	$13.30M	$75.59M	$26.02M	$49.48M	$42.51M	$15.77M	$20.60M	-$92.11M	-$86.29M
EBITDA	-$6.19M	$2.26M	$12.90M	$14.67M	$26.76M	$24.66M	$66.17M	$37.19M	$29.48M	$27.28M	-$56.37M	-$67.72M
EPS (basic)	$-0.04	$0.01	$0.05	$0.06	$0.35	$0.11	$0.22	$0.19	$0.07	$0.09	$-0.40	$-0.37
EPS (diluted)	$-0.04	$0.01	$0.05	$0.06	$0.32	$0.10	$0.20	$0.17	$0.06	$0.08	$-0.40	$-0.37
Diluted shares	210.13M	767.81K	229.36M	234.79M	235.07M	3.66M	246.61M	256.78M	248.68M	2.68M	228.36M	231.75M
Gross margin	82.6%	82.7%	82.4%	81.3%	79.2%	76.8%	73.5%	76.4%	73.8%	71.9%	65.2%	63.8%
Operating margin	-3.8%	-0.2%	3.6%	3.5%	5.6%	3.9%	9.9%	4.9%	2.0%	1.5%	-12.9%	-12.9%
Net margin	-3.3%	0.5%	4.0%	4.2%	18.8%	5.4%	8.4%	7.8%	2.6%	3.3%	-15.1%	-11.5%

Balance sheet

quarters · USD

Quarter ended	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Cash & equivalents	$58.00M	$96.66M	$105.24M	$129.29M	$165.52M	$220.58M	$273.74M	$1.12B	$345.78M	$228.62M	$222.27M	$609.81M
Short-term investments	$154.50M	$124.32M	$98.36M	$98.00M	$88.55M	$79.67M	$48.94M	$20.03M	$283.97M	$348.88M	$528.61M	$231.24M
Receivables	—	$6.70M	—	—	—	$6.10M	—	—	—	$32.10M	$149.62M	$375.29M
Inventory	$21.99M	$22.46M	$29.83M	$40.59M	$49.11M	$64.43M	$76.10M	$141.80M	$105.99M	$80.13M	$79.07M	$87.78M
Total current assets	$250.22M	$265.05M	$261.73M	$290.92M	$326.38M	$395.83M	$446.96M	$1.36B	$845.26M	$767.64M	$1.05B	$1.38B
Goodwill	$110.88M	$110.88M	$110.88M	$110.88M	$112.73M	$112.73M	$117.75M	$117.75M	$259.24M	$278.32M	$342.84M	$1.10B
Total assets	$413.87M	$441.19M	$448.11M	$480.50M	$602.26M	$707.54M	$891.71M	$1.88B	$2.23B	$2.15B	$2.27B	$3.63B
Total current liabilities	$82.55M	$88.47M	$93.32M	$108.67M	$152.65M	$221.37M	$280.36M	$272.23M	$450.79M	$404.43M	$618.78M	$1.48B
Total liabilities	$85.30M	$97.16M	$103.62M	$118.53M	$162.21M	$230.82M	$342.45M	$1.31B	$1.65B	$1.61B	$1.82B	$3.30B
Shareholders' equity	$328.56M	$344.03M	$344.48M	$361.97M	$440.05M	$476.72M	$549.26M	$562.70M	$580.98M	$540.93M	$446.17M	$324.07M

Cash flow

quarters · USD

Quarter ended	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Operating cash flow	$25.19M	$21.98M	$25.84M	$53.59M	$85.27M	$86.39M	$109.09M	-$19.12M	$148.72M	$61.31M	$89.36M	-$35.94M
Capital expenditures	—	—	$14.00M	$6.00M	$5.90M	$26.90M	$59.00M	$50.40M	$69.40M	$63.90M	$36.30M	$32.30M
Free cash flow	$25.19M	$21.98M	$11.84M	$47.59M	$79.37M	$59.48M	$50.09M	-$69.52M	$79.32M	-$2.59M	$53.06M	-$68.24M
Investing cash flow	-$31.06M	$20.70M	$13.04M	-$4.47M	-$10.41M	-$17.21M	-$32.80M	-$21.09M	-$887.40M	-$83.68M	-$15.45M	$84.54M
Financing cash flow	-$1.56M	-$3.96M	-$30.31M	-$25.07M	-$38.82M	-$13.65M	-$23.02M	$889.17M	-$39.01M	-$97.52M	-$77.88M	$341.76M
Share buybacks	$0	$2.00M	$28.06M	$19.93M	$30.04M	$5.00M	$0	$0	$9.48M	$80.48M	—	—
Stock-based compensation	$17.28M	$17.79M	$19.03M	$24.04M	$24.90M	$24.35M	$24.86M	$35.73M	$40.17M	$34.49M	$36.86M	$42.12M
Depreciation & amortization	$2.36M	$2.66M	$3.00M	$3.64M	$4.38M	$6.06M	$8.28M	$10.46M	$17.67M	$18.09M	$21.95M	$29.48M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.